{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "regulatory-applications", "type": "clause", "offset": [6, 29]}, {"key": "marketing-authorizations", "type": "definition", "offset": [74, 98]}, {"key": "written-materials", "type": "definition", "offset": [108, 125]}, {"key": "regulatory-authority", "type": "clause", "offset": [173, 193]}, {"key": "to-develop", "type": "definition", "offset": [246, 256]}, {"key": "licensed-products", "type": "definition", "offset": [291, 308]}, {"key": "in-the-field", "type": "clause", "offset": [309, 321]}], "size": 509, "snippet": "means regulatory applications, submissions, notifications, registrations, Marketing Authorizations or other written materials, correspondence, submissions made to or with a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize the Licensed Products in the Field in a particular country.", "samples": [{"hash": "3MZu6I6lBwk", "uri": "/contracts/3MZu6I6lBwk#regulatory-materials", "label": "License and Option Agreement (Spark Therapeutics, Inc.)", "score": 28.1594791412, "published": true}, {"hash": "liqthmZPnfM", "uri": "/contracts/liqthmZPnfM#regulatory-materials", "label": "License and Option Agreement (Selecta Biosciences Inc)", "score": 28.1211490631, "published": true}, {"hash": "8M0kcyiVCW4", "uri": "/contracts/8M0kcyiVCW4#regulatory-materials", "label": "License and Option Agreement (Selecta Biosciences Inc)", "score": 27.9514026642, "published": true}], "hash": "6503f6d99be8ca397d4cd17c402266e0", "id": 1}, {"snippet_links": [{"key": "regulatory-applications", "type": "clause", "offset": [6, 29]}, {"key": "regulatory-approvals", "type": "clause", "offset": [106, 126]}, {"key": "filings-made", "type": "clause", "offset": [136, 148]}, {"key": "regulatory-authority", "type": "clause", "offset": [197, 217]}, {"key": "to-develop", "type": "definition", "offset": [227, 237]}, {"key": "licensed-product", "type": "definition", "offset": [271, 287]}], "size": 27, "snippet": "means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals or other filings made to, received from or otherwise conducted with a Regulatory Authority in order to Develop, Manufacture, or Commercialize a Licensed Product in a particular country or jurisdiction.", "samples": [{"hash": "leECdo67oNW", "uri": "/contracts/leECdo67oNW#regulatory-materials", "label": "License and Collaboration Agreement (Alpine Immune Sciences, Inc.)", "score": 33.2053375244, "published": true}, {"hash": "kZc2XoGdEdr", "uri": "/contracts/kZc2XoGdEdr#regulatory-materials", "label": "License and Collaboration Agreement (Molecular Partners Ag)", "score": 32.3045845032, "published": true}, {"hash": "gXIoiYWQIyl", "uri": "/contracts/gXIoiYWQIyl#regulatory-materials", "label": "Discovery Alliance Agreement (Molecular Partners Ag)", "score": 32.3045845032, "published": true}], "hash": "9c91086cc41f5b3765cbfd96eea65d33", "id": 2}, {"snippet_links": [{"key": "regulatory-submissions", "type": "clause", "offset": [10, 32]}, {"key": "the-fda", "type": "clause", "offset": [145, 152]}, {"key": "material-communications", "type": "definition", "offset": [180, 203]}, {"key": "all-other-reports", "type": "clause", "offset": [235, 252]}, {"key": "each-case", "type": "definition", "offset": [312, 321]}, {"key": "relate-to", "type": "definition", "offset": [338, 347]}], "size": 25, "snippet": "means all regulatory submissions and filings or registrations, including any INDs, NDAs, certifications or approvals, made with or received from the FDA and all correspondence and material communications related thereto, together with all other reports or correspondence provided to or received from the FDA, in each case which primarily relate to the API or any Product.", "samples": [{"hash": "aaxCzfq8El6", "uri": "/contracts/aaxCzfq8El6#regulatory-materials", "label": "License Agreement (Jazz Pharmaceuticals Inc)", "score": 21.3422317505, "published": true}, {"hash": "6WbAiOkc8RC", "uri": "/contracts/6WbAiOkc8RC#regulatory-materials", "label": "License Agreement (Jazz Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "5P1G6awFJTo", "uri": "/contracts/5P1G6awFJTo#regulatory-materials", "label": "License Agreement (Jazz Pharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "0b057fae5ebc418aa79b29a5bfc8ed65", "id": 3}, {"snippet_links": [{"key": "regulatory-registrations", "type": "definition", "offset": [10, 34]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [50, 78]}, {"key": "supplements-and-amendments", "type": "clause", "offset": [109, 135]}, {"key": "pricing-and-reimbursement-approvals", "type": "clause", "offset": [162, 197]}, {"key": "regulatory-approvals", "type": "clause", "offset": [224, 244]}, {"key": "other-submissions", "type": "clause", "offset": [249, 266]}, {"key": "regulatory-authority", "type": "clause", "offset": [287, 307]}, {"key": "for-research", "type": "clause", "offset": [308, 320]}, {"key": "conduct-of-clinical-trials", "type": "clause", "offset": [349, 375]}, {"key": "diagnostic-product", "type": "definition", "offset": [435, 453]}, {"key": "regulatory-jurisdiction", "type": "definition", "offset": [459, 482]}, {"key": "correspondence-to", "type": "clause", "offset": [510, 527]}, {"key": "authority-and", "type": "clause", "offset": [551, 564]}, {"key": "documents-referenced", "type": "clause", "offset": [569, 589]}, {"key": "drug-master-files", "type": "definition", "offset": [656, 673]}, {"key": "license-applications", "type": "definition", "offset": [716, 736]}, {"key": "the-foregoing", "type": "definition", "offset": [779, 792]}], "size": 15, "snippet": "means the regulatory registrations, applications, authorizations and approvals (including approvals of MAAs, supplements and amendments, pre- and post-approvals, pricing and reimbursement approvals, and labeling approvals), Regulatory Approvals and other submissions made to or with any Regulatory Authority for research, development (including the conduct of Clinical Trials), manufacture, or commercialization of a pharmaceutical or diagnostic product in a regulatory jurisdiction, together with all related correspondence to or from any Regulatory Authority and all documents referenced in the complete regulatory chronology for each MAA, including all Drug Master Files (if any), INDs and supplemental biologics license applications (sBLAs) and foreign equivalents of any of the foregoing.", "samples": [{"hash": "ggWzV6DNN5I", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001559053/ae6ab6b1-0a4c-47d6-88c1-a6bd26eff5f5.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 11.1834363937, "published": false}, {"hash": "lyfw2iTUiGh", "uri": "http://ir.prothena.com/static-files/d05d9a13-6758-43d5-b94f-5384acea243a", "label": "ir.prothena.com", "score": 10.1704311371, "published": false}, {"hash": "8KoU4G8OPIU", "uri": "http://ir.prothena.com/static-files/191fa62b-dd1c-48c8-816b-fedca6491251", "label": "ir.prothena.com", "score": 10.1704311371, "published": false}], "hash": "c8ae5c469eaee6ffddba86ce06b05eeb", "id": 4}, {"snippet_links": [{"key": "regulatory-approvals", "type": "clause", "offset": [58, 78]}, {"key": "supplements-and-amendments", "type": "clause", "offset": [109, 135]}, {"key": "pricing-approvals", "type": "definition", "offset": [162, 179]}, {"key": "other-submissions", "type": "clause", "offset": [208, 225]}, {"key": "regulatory-authority", "type": "clause", "offset": [246, 266]}, {"key": "drug-master-files", "type": "definition", "offset": [278, 295]}, {"key": "for-research", "type": "clause", "offset": [297, 309]}, {"key": "conduct-of-clinical-trials", "type": "clause", "offset": [338, 364]}, {"key": "biological-product", "type": "definition", "offset": [423, 441]}, {"key": "regulatory-jurisdiction", "type": "definition", "offset": [447, 470]}, {"key": "correspondence-to", "type": "clause", "offset": [498, 515]}, {"key": "authority-and", "type": "clause", "offset": [539, 552]}, {"key": "documents-referenced", "type": "clause", "offset": [557, 577]}, {"key": "the-foregoing", "type": "definition", "offset": [673, 686]}], "size": 13, "snippet": "means the registrations, applications, authorizations and Regulatory Approvals (including approvals of \u2587\u2587\u2587\u2587, supplements and amendments, pre- and post-approvals, Pricing Approvals and labeling approvals) and other submissions made to or with any Regulatory Authority, including drug master files, for research, Development (including the conduct of Clinical Trials), Manufacture or Commercialization of a pharmaceutical or biological product in a regulatory jurisdiction, together with all related correspondence to or from any Regulatory Authority and all documents referenced in the complete regulatory chronology for each NDA, MAA, IND and foreign equivalents of any of the foregoing.", "samples": [{"hash": "hXQ94o6SEx3", "uri": "/contracts/hXQ94o6SEx3#regulatory-materials", "label": "Collaboration and License Agreement (Nurix Therapeutics, Inc.)", "score": 35.1218338013, "published": true}, {"hash": "6Z7t0EGlnra", "uri": "/contracts/6Z7t0EGlnra#regulatory-materials", "label": "Collaboration and License Agreement (Nurix Therapeutics, Inc.)", "score": 34.7768669128, "published": true}], "hash": "c944b5ba5c716b496ff6bb220d2e0fdf", "id": 5}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "regulatory-authority", "type": "clause", "offset": [134, 154]}, {"key": "in-order-to", "type": "clause", "offset": [195, 206]}, {"key": "applicable-field", "type": "definition", "offset": [235, 251]}, {"key": "in-the-territory", "type": "clause", "offset": [252, 268]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [270, 296]}, {"key": "regulatory-approval-applications", "type": "definition", "offset": [374, 406]}, {"key": "regulatory-approvals", "type": "clause", "offset": [408, 428]}, {"key": "pricing-approvals", "type": "definition", "offset": [430, 447]}, {"key": "amendments-and-supplements", "type": "clause", "offset": [452, 478]}, {"key": "the-foregoing", "type": "definition", "offset": [490, 503]}, {"key": "in-person", "type": "clause", "offset": [567, 576]}], "size": 12, "snippet": "means, with respect to each Product, all documentation, correspondence, submissions and notifications submitted to or received from a Regulatory Authority that are necessary or reasonably useful in order to Exploit such Product in the applicable field in the Territory. For the avoidance of doubt, Regulatory Materials shall include, with respect to each Product, all INDs, Regulatory Approval Applications, Regulatory Approvals, Pricing Approvals and amendments and supplements for any of the foregoing, as well as the contents of any minutes from meetings (whether in person or by audio conference or videoconference) with a Regulatory Authority.", "samples": [{"hash": "guruHdLx0fp", "uri": "/contracts/guruHdLx0fp#regulatory-materials", "label": "Common Stock Purchase Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 27.9459266663, "published": true}, {"hash": "g8f4OnZ6Dy2", "uri": "/contracts/g8f4OnZ6Dy2#regulatory-materials", "label": "License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 27.9459266663, "published": true}, {"hash": "jLhS74mWt83", "uri": "/contracts/jLhS74mWt83#regulatory-materials", "label": "License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 27.6036968231, "published": true}], "hash": "9dd75441f047f01058faec6e55c99c76", "id": 6}, {"snippet_links": [{"key": "regulatory-applications", "type": "clause", "offset": [6, 29]}, {"key": "filings-made", "type": "clause", "offset": [104, 116]}, {"key": "regulatory-authority", "type": "clause", "offset": [130, 150]}, {"key": "to-develop", "type": "definition", "offset": [203, 213]}, {"key": "offer-to-sell", "type": "clause", "offset": [234, 247]}, {"key": "licensed-product", "type": "definition", "offset": [311, 327]}, {"key": "in-the-field", "type": "clause", "offset": [328, 340]}, {"key": "the-territory", "type": "clause", "offset": [345, 358]}, {"key": "related-to", "type": "clause", "offset": [385, 395]}, {"key": "regulatory-approval", "type": "clause", "offset": [396, 415]}, {"key": "issued-by", "type": "definition", "offset": [416, 425]}], "size": 11, "snippet": "means regulatory applications (including BLAs), submissions, notifications, registrations, and/or other filings made to or with a Regulatory Authority that are necessary or reasonably desirable in order to develop, use, import, sell, offer to sell, register, market, manufacture, or otherwise commercialize the Licensed Product in the Field for the Territory, along with any documents related to Regulatory Approval issued by a Regulatory Authority for the Territory.", "samples": [{"hash": "6Gc5pbklRed", "uri": "/contracts/6Gc5pbklRed#regulatory-materials", "label": "Development and License Agreement (Immunomedics Inc)", "score": 28.7125263214, "published": true}, {"hash": "75kHSbJOW1a", "uri": "/contracts/75kHSbJOW1a#regulatory-materials", "label": "Development and License Agreement (Immunomedics Inc)", "score": 28.7043113708, "published": true}, {"hash": "33aUFqdAfFW", "uri": "/contracts/33aUFqdAfFW#regulatory-materials", "label": "Development and License Agreement (Seattle Genetics Inc /Wa)", "score": 28.7043113708, "published": true}], "hash": "23b28b73d3bcbbcde0c885e9adcde7bb", "id": 7}, {"snippet_links": [{"key": "regulatory-registrations", "type": "definition", "offset": [10, 34]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [50, 78]}, {"key": "supplements-and-amendments", "type": "clause", "offset": [109, 135]}, {"key": "pricing-and-reimbursement-approvals", "type": "clause", "offset": [162, 197]}, {"key": "regulatory-approvals", "type": "clause", "offset": [224, 244]}, {"key": "other-submissions", "type": "clause", "offset": [249, 266]}, {"key": "regulatory-authority", "type": "clause", "offset": [287, 307]}, {"key": "for-research", "type": "clause", "offset": [308, 320]}, {"key": "conduct-of-clinical-trials", "type": "clause", "offset": [349, 375]}, {"key": "diagnostic-product", "type": "definition", "offset": [435, 453]}, {"key": "regulatory-jurisdiction", "type": "definition", "offset": [459, 482]}, {"key": "correspondence-to", "type": "clause", "offset": [510, 527]}, {"key": "authority-and", "type": "clause", "offset": [551, 564]}, {"key": "documents-referenced", "type": "clause", "offset": [569, 589]}, {"key": "drug-master-files", "type": "definition", "offset": [656, 673]}, {"key": "license-applications", "type": "definition", "offset": [716, 736]}, {"key": "the-foregoing", "type": "definition", "offset": [779, 792]}], "size": 10, "snippet": "means the regulatory registrations, applications, authorizations and approvals (including approvals of \u2587\u2587\u2587\u2587, supplements and amendments, pre- and post-approvals, pricing and reimbursement approvals, and labeling approvals), Regulatory Approvals and other submissions made to or with any Regulatory Authority for research, development (including the conduct of Clinical Trials), manufacture, or commercialization of a pharmaceutical or diagnostic product in a regulatory jurisdiction, together with all related correspondence to or from any Regulatory Authority and all documents referenced in the complete regulatory chronology for each MAA, including all Drug Master Files (if any), INDs and supplemental biologics license applications (sBLAs) and foreign equivalents of any of the foregoing.", "samples": [{"hash": "2ygNhRQXI3J", "uri": "/contracts/2ygNhRQXI3J#regulatory-materials", "label": "u.s. License Agreement (Prothena Corp Public LTD Co)", "score": 32.8412055969, "published": true}, {"hash": "1PRlwCf6H1w", "uri": "/contracts/1PRlwCf6H1w#regulatory-materials", "label": "Master Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "jyCPZUGoLnP", "uri": "/contracts/jyCPZUGoLnP#regulatory-materials", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.6242294312, "published": true}], "hash": "83b99e85b226a13f926f3fc450f47fc7", "id": 8}, {"snippet_links": [{"key": "regulatory-registrations", "type": "definition", "offset": [10, 34]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [50, 78]}, {"key": "supplements-and-amendments", "type": "clause", "offset": [109, 135]}, {"key": "reimbursement-approvals", "type": "clause", "offset": [186, 209]}, {"key": "regulatory-approvals", "type": "clause", "offset": [236, 256]}, {"key": "other-submissions", "type": "clause", "offset": [260, 277]}, {"key": "regulatory-authority", "type": "clause", "offset": [298, 318]}, {"key": "necessary-for", "type": "definition", "offset": [319, 332]}, {"key": "the-research", "type": "clause", "offset": [333, 345]}, {"key": "conduct-of-clinical-trials", "type": "clause", "offset": [374, 400]}, {"key": "regulatory-jurisdiction", "type": "definition", "offset": [455, 478]}, {"key": "correspondence-to", "type": "clause", "offset": [506, 523]}, {"key": "authority-and", "type": "clause", "offset": [547, 560]}, {"key": "documents-referenced", "type": "clause", "offset": [565, 585]}, {"key": "the-eu", "type": "clause", "offset": [694, 700]}, {"key": "new-drug-applications", "type": "clause", "offset": [723, 744]}, {"key": "the-foregoing", "type": "definition", "offset": [786, 799]}], "size": 10, "snippet": "means the regulatory registrations, applications, authorizations and approvals (including approvals of BLAs, supplements and amendments, pre- and post-approvals, pricing and Third Party reimbursement approvals, and labeling approvals), Regulatory Approvals or other submissions made to or with any Regulatory Authority necessary for the research, Development (including the conduct of Clinical Trials), Manufacture, or Commercialization of a Product in a regulatory jurisdiction, together with all related correspondence to or from any Regulatory Authority and all documents referenced in the complete regulatory chronology for each BLA, including all Drug Master File(s) (if any), IND, CTA in the EU, MAA and supplemental new drug applications (sNDAs) or foreign equivalents of any of the foregoing.", "samples": [{"hash": "hLWQhrlGWH0", "uri": "/contracts/hLWQhrlGWH0#regulatory-materials", "label": "Collaboration and License Agreement (Carisma Therapeutics Inc.)", "score": 36.6577682495, "published": true}, {"hash": "iL6zPI7vxMD", "uri": "/contracts/iL6zPI7vxMD#regulatory-materials", "label": "Collaboration and License Agreement (Sesen Bio, Inc.)", "score": 33.8898010254, "published": true}, {"hash": "8KVojHNGz4X", "uri": "/contracts/8KVojHNGz4X#regulatory-materials", "label": "Collaboration and License Agreement (Sesen Bio, Inc.)", "score": 33.7830238342, "published": true}], "hash": "011f8dddafa4bc2fbdfe241cff296a48", "id": 9}, {"snippet_links": [{"key": "regulatory-applications", "type": "clause", "offset": [27, 50]}, {"key": "fda-and-other-regulatory-authorities", "type": "clause", "offset": [128, 164]}, {"key": "relating-to", "type": "definition", "offset": [165, 176]}, {"key": "without-limitation", "type": "clause", "offset": [254, 272]}, {"key": "investigational-medicinal-product", "type": "definition", "offset": [274, 307]}, {"key": "clinical-trial", "type": "definition", "offset": [318, 332]}, {"key": "applications-and-approvals", "type": "clause", "offset": [333, 359]}, {"key": "drug-applications", "type": "definition", "offset": [371, 388]}], "size": 8, "snippet": "means all U.S. and foreign regulatory applications, submissions and approvals for the Compound, and all correspondence with the FDA and other Regulatory Authorities relating to the Compound or any such applications, submissions and approvals, including, without limitation, investigational medicinal product dossiers, Clinical Trial Applications and approvals and orphan drug applications and approvals.", "samples": [{"hash": "7WND9Lm770P", "uri": "/contracts/7WND9Lm770P#regulatory-materials", "label": "Asset Purchase Agreement (Cti Biopharma Corp)", "score": 24.8459949493, "published": true}, {"hash": "3HbayArTRpQ", "uri": "http://investors.ctibiopharma.com/static-files/ca000575-e352-4051-90fb-a9b53a219930", "label": "Amendment", "score": 13.96235466, "published": false}, {"hash": "gZrAt8mEIqk", "uri": "https://investors.ctibiopharma.com/static-files/ca000575-e352-4051-90fb-a9b53a219930", "label": "Amendment", "score": 13.8076658249, "published": false}], "hash": "db6039fa22da2fe10ddb536616b89dbc", "id": 10}], "next_curs": "CmESW2oVc35sYXdpbnNpZGVyY29udHJhY3Rzcj0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIdcmVndWxhdG9yeS1tYXRlcmlhbHMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Regulatory Materials", "size": 1024, "snippet": "means regulatory applications, submissions, notifications, registrations, Marketing Authorizations or other written materials, correspondence, submissions made to or with a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize the Licensed Products in the Field in a particular country.", "id": "regulatory-materials", "examples": ["As between the Parties, but subject to Section 11.7 (Ionis Reversion Right), EnCarda shall own all <strong>Regulatory Materials</strong>, and other regulatory documentation in the Territory with respect to the Licensed Compound and all Licensed Products."], "related": [["regulatory-filings", "Regulatory Filings", "Regulatory Filings"], ["regulatory-data", "Regulatory Data", "Regulatory Data"], ["regulatory-filing", "Regulatory Filing", "Regulatory Filing"], ["regulatory-documentation", "Regulatory Documentation", "Regulatory Documentation"], ["study-materials", "Study Materials", "Study Materials"]], "related_snippets": [], "updated": "2026-07-04T05:45:54+00:00"}, "json": true, "cursor": ""}}